| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-19 08:16 Tx date 2025-12-19 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,965
+8,500 vol $1.29 each |
12,400 | |
| Filed 2025-12-19 08:11 Tx date 2025-12-19 |
$INM
InMed Pharmaceuticals Inc. |
Bathery, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,257
+1,750 vol $1.29 each |
5,250 | |
| Filed 2025-12-19 08:09 Tx date 2025-12-19 |
$INM
InMed Pharmaceuticals Inc. |
Klompas, Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,257
+1,750 vol $1.29 each |
5,250 | |
| Filed 2025-12-19 08:07 Tx date 2025-12-19 |
$INM
InMed Pharmaceuticals Inc. |
Lemerond, Nicole
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,257
+1,750 vol $1.29 each |
2,725 | |
| Filed 2025-12-19 08:05 Tx date 2025-12-19 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,257
+1,750 vol $1.29 each |
2,711 | |
| Filed 2025-12-19 08:03 Tx date 2025-12-19 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,770
+13,000 vol $1.29 each |
18,280 | |
| Filed 2025-12-19 08:01 Tx date 2025-12-19 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,220
+18,000 vol $1.29 each |
25,445 | |
| Filed 2025-12-19 07:59 Tx date 2025-12-19 |
$INM
InMed Pharmaceuticals Inc. |
Jagpal, Netta
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,220
+18,000 vol $1.29 each |
24,250 | |
| Filed 2025-12-19 07:57 Tx date 2025-12-19 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$45,150
+35,000 vol $1.29 each |
49,050 | |
| Filed 2025-12-16 11:30 Tx date 2025-12-15 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-481,250
-250 vol $1,925 each |
14,050 | |
| Filed 2025-12-16 11:26 Tx date 2025-12-15 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-115,500
-60 vol $1,925 each |
7,445 | |
| Filed 2025-12-16 11:23 Tx date 2025-12-15 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-134,750
-70 vol $1,925 each |
5,280 | |
| Filed 2025-12-16 11:17 Tx date 2025-12-15 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-26,950
-14 vol $1,925 each |
961 | |
| Filed 2025-10-24 14:32 Tx date 2025-10-14 |
$INM
InMed Pharmaceuticals Inc. |
Bathery, John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,500 | ||
| Filed 2025-10-24 14:26 Tx date 2025-10-16 |
$INM
InMed Pharmaceuticals Inc. |
Bathery, John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-20 12:02 Tx date 2025-10-09 |
$INM
InMed Pharmaceuticals Inc. |
Klompas, Neil
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,500 | ||
| Filed 2025-02-02 10:04 Tx date 2025-01-11 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2 vol |
975 | |
| Filed 2025-01-24 12:37 Tx date 2024-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-11,575 vol |
608 | |
| Filed 2024-12-22 12:10 Tx date 2024-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-11,574 vol |
||
| Filed 2025-01-10 16:53 Tx date 2024-12-20 |
$INM
InMed Pharmaceuticals Inc. |
Jagpal, Netta
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,524
+3,750 vol $4.14 each |
6,250 |